A PET study assessing vesicular monoamine transporter 2 (VMAT2) availability estimated the premotor phase to be about 10 years in PD patients with an AAO of 70 years by fitting a negative exponential curve3. The gene discussed is SLC18A2; the disease is Parkinson disease.